Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HepVac hepatitis A and B vaccination study in HIV-1-infected adults
2009-016773-15Phase 4Terminated
- Sponsor
- Matti Ristola
- Start
- Oct 2009
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hepatitis b vaccine recombinant, Hepatitis A virus vaccine and hepatitis B vaccine recombinant in hepatitis A (HAV) and hepatitis B (HBV) (3 arms), sponsored by Matti Ristola. Started Oct 2009; status: terminated.
02
Drugs
hepatitis b vaccine recombinantHepatitis A virus vaccinehepatitis B vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2009-016773-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016773-15.